On-demand healthcare service ‘mfine’ launched in Delhi-NCR

Having partnered with top hospitals to enable virtual medical consultations in the next 6 months, mfine plans to sign up with 75 hospitals and more than 500 doctors in Delhi NCR

0
45
Download PDF

New Delhi: mfine, an AI powered, on-demand healthcare service which enables virtual medical consultations, is now live in Delhi-NCR. mfine is an always-on health companion for consumers, enabling them to consult doctors within 60 secs, anytime and from anywhere.

mfine has partnered with city’s leading hospitals which include CK Birla Hospital for Women, Sarvodaya Hospital & Research Centre, Asian Hospital and Institute of Medical Sciences, Cloudnine Hospital, Aakash Hospital, Paras Hospitals, Medeor Hospitals, Mother land Hospitals, and Orchid Hospital Maternity and Heart Centre. Currently, DelhiNCR accounts for 15% of consultations done on mfine. To address this demand and increase accessibility for consumers in DelhiNCR, mfine plans to sign up 75 hospitals and more than 500 doctors in the next 6 months. The company will also expand into all relevant pockets of the growing NCR.

mfine’s mhealth solution enables users to consult with doctors, virtually and when they need. The consultation covers complete diagnoses and a valid digital prescription. Users can also securely store their health records and track various health parameters for themselves and for the entire family. Doctors are able to get structured inputs on the patient’s history via chat, video, images, documents etc. On mfine, not only are users consulting for episodic illnesses like viral infections but also for chronic diseases such as diabetes and arthritis. Patients are also consulting for super specialties such as cardiology, orthopedics and fertility. The startup will soon launch additional services such as monitoring of vitals, collection of samples for lab tests and medicine delivery at home. Several digital tools are also in the pipeline to help users track chronic conditions, maintain a healthy lifestyle, and aid recovery – depending on user requirements.

At the core of mfine is its powerful AI-powered diagnosis engine which assists doctors and improves their efficiency & effectiveness dramatically. The AI system is able to collect detailed information from the patients and suggest accurate diagnosis and treatment plans for doctors, enabling them to treat more patients efficiently and effectively. The machine learning algorithms embedded with deep medical protocols help doctors deliver high quality care consistently at large scale.

mfine follows a unique model of partnering with leading and trusted hospitals instead of aggregating individual doctors on its platform. Hospital partnerships enable mfine to make high quality care of trusted doctors available on a digital channel – for the first time in the country. For the hospitals, mfine is their new center on the cloud bringing in more patients and offering premium services, long-term care programs, super specialties without any upfront investments.

India has one doctor for every 1700 people, and if one considers only post-graduates, this ratio is pretty dismal at one doctor for every 5000 people. Spread of chronic and lifestyle diseases is growing at an alarming pace and much of it will end up in tertiary care if not managed and intervened at an appropriate time. mfine’s vision is to enable easy access to quality primary and secondary care in India so that tertiary can be avoided. The company wants to encourage a prevention mindset among consumers and help them manage their health better.

The startup believes that on-demand service solves not just convenience of access but also allows for early detection of health issues, makes it easy to track health and recovery, and makes follow-ups effortless and improves medication compliance. mfine will expand into the 40 cities in India over the next couple of years and bring the top doctors of the country onto its digital platform – making them much more accessible and helping them bring their high-quality healthcare to millions of people across the country.

As per Prasad Kompalli, CEO and cofounder, mfine, “Doctors are loving the system as they are assisted by the state-of-the-art AI tech and they are more productive and effective with mfine. mfine has already built a strong provider network in Bangalore, Hyderabad and Pune and now will bring some of the top specialist doctors and best hospitals of Delhi NCR region onto our network. People of Delhi NCR would be able to access top specialist doctors from best hospitals of the city online instantly.”

Akshat Seth, Chief Operating Officer, CK Birla Hospital for Women said, “mfine is impacting the way doctors and patients interact. Since we implemented it, we have been able to provide our patients access to quality medical guidance from our expert doctors remotely. It has also helped our doctors stay connected with their patients even when they are unable to visit the hospital.”

In his comments, Dr Sameer Kulkarni, Facility Director, Paras Hospitals, Gurgaon mentioned, “mfine team meticulously prepares data for each and every case, ensures timely follow-ups and reminders. This makes the experience more comfortable for the provider as well as for the patient. Doctors can focus on giving quality treatment and spend their time with the patient more productively, which impacts the healthcare outcomes in a positive manner.”

Launched in December 2017, first in Bengaluru, more than 3,00,000 transactions across doctors consuls, diagnostics tests and e-pharmacy have been done on mfine so far. The startup has over 600 doctors from 175 leading hospitals consulting across 22 different specialties. mfine has raised nearly $25 million and has 300 employees. The company is planning to achieve over 20,00,000 consultations by this financial year and will partner with more than 300 top hospitals and healthcare partners across the country. mfine recently launched its corporate and annual subscription plan for consumers which will soon be available in DelhiNCR.

The mfine app is currently available in English on Google Playstore and Appstore.